SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A nationwide FAA ground stop after communications problems became the main immediate focus as QQQ sold off after hours; traders speculated about a cyberattack, while others said a technical outage could explain it. The broader debate also centered on pressure in AI and tech stocks amid Nvidia leadership uncertainty and concerns about AI spending, with dip buyers and bears split on what comes next.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is drawing attention ahead of the FDAs PDUFA decision on ivonescimab plus chemotherapy for EGFR-mutated lung cancer. Traders are divided between approval and a possible rejection or delay, focusing on strong progression-free-survival results and favorable updated survival trends versus the FDAs stated need for statistically significant overall-survival evidence; recent selling has also prompted unverified speculation about a negative outcome.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius selloff is being tied to its earnings outlook and delays in activating third-party data-center capacity, which push expected revenue into a later period and have prompted analyst price-target cuts. Traders are divided between viewing the execution and heavy-capex concerns as a reason for further downside and treating the drop as an overreaction, with broader weakness in AI and neocloud stocks adding pressure.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines quarterly results and outlook are drawing attention: strong revenue and travel demand are being offset by surging fuel costs, which drove a loss and a weaker full-year outlook. Traders are split between seeing demand and premium-seat growth as support and worrying that elevated fuel costs and AALs debt will keep pressuring profitability.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians volatile, weak share performance is driving debate, with traders blaming heavy short-selling and persistent selling pressure while bulls point to improving deliveries, the R2 ramp, and upcoming autonomy developments. Sentiment remains split between concern over cash burn and execution and hopes that the companys growth initiatives can improve its outlook.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Reported takeover discussions involving Silver Lake and Saudi Arabias PIF are driving speculation, though no deal is confirmed; traders disagree over whether a potential offer would undervalue Unity. The interest is reinforced by strong quarterly results and the companys first GAAP-profitable quarter, with bullish call activity and breakout chatter alongside skepticism about the rally.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The upcoming Phase 3 REGAL trial readout for SELLASs AML treatment GPS dominates discussion, with traders focused on the binary clinical catalyst. Bulls anticipate strong results, while skeptics cite the stocks sharp volatility and warn of failure risk or a sell-the-news reaction; claims of short-term manipulation remain speculation.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novos stronger-than-expected quarterly results and raised full-year outlook, driven largely by demand for its Wegovy pill, have fueled renewed buying interest. Traders are debating whether the oral drugs momentum can support a sustained recovery amid Lilly competition and concerns about Novos execution.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs abrupt departure is driving debate over Nvidias leadership transition, with traders speculating about his return and possible successors while others worry about leadership uncertainty and scrutiny of chip exports to China. Bulls argue Nvidias business remains strong and point to earnings, while bears see unresolved risks weighing on confidence.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

A nationwide FAA ground stop has traders weighing potential disruption to Delta and other airlines against the stocks relatively muted reaction; some are testing short positions while others note it recovered after-hours. 

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ZenaTech, Inc. (Nasdaq: $ZENA ) announces that its ZenaDrone subsidiary has signed a memorandum of understanding (MOU) with Rattler Medical Inc., a developer and manufacturer of temperature-controlled containers for transporting human blood. Under the MOU, the two companies will cooperate to develop and manufacture a drone-driven battlefield blood delivery system designed to move temperature-controlled blood to military medical personnel on the battlefield more quickly and efficiently. 
 
ZenaTech, Inc. is a B2i Digital Featured Company. See the company&#39;s in-depth profile at: https://b2idigital.com/zenatech-1 
 
The planned system combines Rattler Medical’s far-forward blood resupply capability with ZenaDrone’s payload delivery capability, with a prototype and a U.S. military demonstration planned: 
 
• The container is expected to be carried as payload beneath a ZenaDrone aircraft and either released from the air or delivered on landing 
 
• The companies plan to develop and test a prototype, with the prototype expected to be complete within the next three months 
 
• ZenaDrone is currently planning to demonstrate the system at a U.S. military facility in the summer 2027 
 
Regarding the MOU, Shaun Passley, Ph.D., CEO of ZenaTech, stated: &quot;This MOU pairs ZenaDrone’s cargo drone capability with a container system built by a team that has carried blood in the field.&quot; 
 
Read the full release: https://www.zenatech.com/zenatechs-zenadrone-signs-mou-with-rattler-medical-to-develop-drone-based-battlefield-blood-delivery-system/ 
 
ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) is a technology company that specializes in AI autonomy drone platforms to transform commercial, government, and defense sectors. Its subsidiaries include drone manufacturing through ZenaDrone, a global Drone as a Service (DaaS) business, and an enterprise SaaS division of software brands. The Company is executing an acquisition-led DaaS roll-up strategy to digitize and automate legacy service industries like land surveys and inspections, driving drone-based scalable, recurring revenue growth. With an operating footprint spanning North America, Europe, the Middle East, Asia, and Australia, ZenaTech is advancing AI drones for applications such as agriculture and logistics, as well as ISR, cargo, and counter-UAS for U.S. defense and NATO allies. The company is investing in next-generation technologies, including drone swarms, quantum computing, and advanced AI autonomy to capture long-term opportunities in key markets through its R&amp;D initiatives. 
 
Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. 
 
David Shapiro, Chief Executive Officer of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted ZENA stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer. 
 
 $RCAT, $ONDS, $DPRO, $ITA

TopOptionsAlerts®

David Shapiro

Linda Scott

Bonnie Siegmund

Craig Salinas

Ariana Storck

Eugene Davenport

Roberta Creech

Henry Callaghan

John Park

Michael Musto

Melissa Vermillion

Shirley Hall

James Adair

Jeanne Hodges

Kelly Distaffen

Micheal Fikes

Nina Studdard

Renee Blankenship

Raymond Oliver

Filomena Marsh

Terry Skora

Lucy Pena

Amber Reilly

Karen Paris

Lillian Ellis

Edwina Packard

Ella Costello

Joseph Weiler

Sue Guajardo

b2i digital - connecting companies and investors through digital marketing, investor conferences, and direct introductions and meetings.

B2idigital

B2i Digital - Connecting companies and investors

Disclaimer - Content is provided "as is" by companies featured on the site. Conduct a trusted advisory before making investments.

Disclaimer - Consult an advisor before making any investments

ZenaTech, Inc. (Nasdaq: ZENA) a Featured Profile on B2i Digital

ZenaTech, Inc. | Nasdaq: ZENA | B2i Digital Featured Company

ZenaTech's ZenaDrone Signs MOU with Rattler Medical to Develop Drone-Based Battlefield Blood Delivery System Targets U.S. military medical logistics by [...]

ZenaTech

ZenaTech's ZenaDrone Signs MOU with Rattler Medical to Develop Drone-Based Battlefield Blood Delivery System - ZenaTech

StockTwits Web

ZenaTech Inc.

Red Cat Holdings Inc

Ondas Inc

Draganfly Inc

iShares Dow Jones US Aerospace & Defense

 ) announces that its ZenaDrone subsidiary has signed a memorandum of understanding (MOU) with Rattler Medical Inc., a developer and manufacturer of temperature-controlled containers for transporting human blood. Under the MOU, the two companies will cooperate to develop and manufacture a drone-driven battlefield blood delivery system designed to move temperature-controlled blood to military medical personnel on the battlefield more quickly and efficiently. 
 
ZenaTech, Inc. is a B2i Digital Featured Company. See the company's in-depth profile at: https://

/zenatech-1 
 
The planned system combines Rattler Medical’s far-forward blood resupply capability with ZenaDrone’s payload delivery capability, with a prototype and a U.S. military demonstration planned: 
 
• The container is expected to be carried as payload beneath a ZenaDrone aircraft and either released from the air or delivered on landing 
 
• The companies plan to develop and test a prototype, with the prototype expected to be complete within the next three months 
 
• ZenaDrone is currently planning to demonstrate the system at a U.S. military facility in the summer 2027 
 
Regarding the MOU, Shaun Passley, Ph.D., CEO of ZenaTech, stated: "This MOU pairs ZenaDrone’s cargo drone capability with a container system built by a team that has carried blood in the field." 
 
Read the full release: 

 
 
ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) is a technology company that specializes in AI autonomy drone platforms to transform commercial, government, and defense sectors. Its subsidiaries include drone manufacturing through ZenaDrone, a global Drone as a Service (DaaS) business, and an enterprise SaaS division of software brands. The Company is executing an acquisition-led DaaS roll-up strategy to digitize and automate legacy service industries like land surveys and inspections, driving drone-based scalable, recurring revenue growth. With an operating footprint spanning North America, Europe, the Middle East, Asia, and Australia, ZenaTech is advancing AI drones for applications such as agriculture and logistics, as well as ISR, cargo, and counter-UAS for U.S. defense and NATO allies. The company is investing in next-generation technologies, including drone swarms, quantum computing, and advanced AI autonomy to capture long-term opportunities in key markets through its R&D initiatives. 
 
Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at 

. 
 
David Shapiro, Chief Executive Officer of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted ZENA stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://

ZenaTech, Inc. is expanding the potential of drone technology through an innovative collaboration between its ZenaDrone subsidiary and Rattler Medical Inc. The planned system could help deliver temperature-controlled blood to battlefield medical teams faster, highlighting the growing role of autonomous drones in defense logistics. 
 
Explore ZenaTech, Inc.’s full B2i Digital Featured Company profile at: https://b2idigital.com/zenatech-1

ZenaTech, Inc. is expanding the potential of drone technology through an innovative collaboration between its ZenaDrone subsidiary and Rattler Medical Inc. The planned system could help deliver temperature-controlled blood to battlefield medical teams faster, highlighting the growing role of autonomous drones in defense logistics. 
 
Explore ZenaTech, Inc.’s full B2i Digital Featured Company profile at: 